Document:

Filed by Automated Filing Services Inc. (604) 609-0244 - NextGen Bioscience Inc. - Exhibit 10.2

EXHIBIT 10.2

THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933 (THE “ACT”), AND ARE PROPOSED TO BE ISSUED IN
RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE ACT
PROVIDED BY REGULATION S PROMULGATED UNDER THE ACT. UPON ANY SALE, SUCH
SECURITIES MAY NOT BE REOFFERED FOR SALE OR RESOLD OR OTHERWISE TRANSFERRED
EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO AN
EFFECTIVE REGISTRATION UNDER THE ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM
REGISTRATION UNDER THE ACT. HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY
NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT.

REGULATION S SUBSCRIPTION AGREEMENT

(FOR NON-U.S. SUBSCRIBERS)

THIS AGREEMENT is made effective as of the date of
acceptance set forth on the execution page to this Agreement.

BETWEEN:

NEXTGEN BIOSCIENCE INC., a
Nevada corporation

(hereinafter called the “Company”)

OF THE FIRST PART

AND:

THE SUBSCRIBER LISTED ON THE
EXECUTION PAGE TO THIS AGREEMENT

(hereinafter called the
“Subscriber”)

OF THE SECOND PART

NOW THEREFORE, in consideration of the premises and the
mutual covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties agree as
follows: 

ARTICLE 1
DEFINITIONS

1.1 Definitions. The following terms will have the
following meanings for all purposes of this Agreement:

(a) “Agreement” shall mean this
Agreement, and all schedules and amendments to the Agreement;

(b) “Closing” shall mean the closing of
the purchase and sale of the Units in accordance with the terms and conditions
of this Agreement;

- 2 -

(c) “Common Stock” means the Common
Stock of the Company with a par value of $0.001 per share;

(d) “Exchange Act” shall mean the
United States Securities Exchange Act of 1934, as amended;

(e) “Subscriber” shall mean the
Subscriber executing the signature page to this Agreement;

(f) “Offering” shall mean the offering
of up to 4,000,000 Units by the Company at the Subscription Price; 

(g) “SEC” shall mean the United States
Securities and Exchange Commission; (h) “Securities” shall mean the Units, the
Shares, the Warrants and the Warrant Shares; (i) “Securities Act” shall mean the
United States Securities Act of 1933, as amended;

(j) "Shares" means those shares of
Common Stock to be purchased by the Subscriber and comprising a portion of the
Units; 

(k) “Subscription Price” means the
subscription price of $0.125 per Unit payable by the Subscriber to the Company
in consideration for the purchase and sale of the Units, in the aggregate amount
of $500,000 and in accordance with Section 2.1 of this Agreement;

(l) “Warrant” means one share purchase
warrant, in the form attached as Schedule B to this Agreement, entitling the
Subscriber to purchase one share of Common Stock of the Company at a price of
$0.25 per share for a two year term following the purchase and sale of the
Units;

(m) "Warrants" means those Warrants to
be purchased by the Subscriber and comprising a portion of the Units; 

(n) “Warrant Shares” means the shares
of common stock issuable upon exercise of the Warrants; 

(o) “Unit” means a unit consisting of
one (1) Share and one (1) whole Warrant; and

(p) “Units” means the aggregate of
4,000,000 Units to be purchased by the Subscriber from the Company in accordance
with the terms and conditions of this Agreement.

1.2      Schedules. The
following schedules are attached to and form part of this Agreement:

Schedule A Definition of U.S. Person

Schedule B Form of Warrant

1.3      Currency. All dollar
amounts referred to in this agreement are in United States funds, unless
expressly stated otherwise.

- 3 -

ARTICLE 2
PURCHASE AND SALE OF SHARES

2.1      Agreement to
Subscribe. Subject to the terms and conditions of this Agreement, the
Subscriber hereby subscribes for and agrees to purchase from the Company an
aggregate of 8,000,000 Units at the Subscription Price. Upon execution of this
Agreement, the subscription by the Subscriber will be irrevocable.

2.2      Acceptance by Company.
Upon execution of this Agreement by the Company, the Company agrees to sell the
Units to the Subscriber for the Subscription Price.

2.3      Payment of Subscription
Price. The Subscription Price is payable by the Subscriber to the Company
prior to or contemporaneously with the execution of this Agreement by the
Subscriber and will be advanced to the Company or its solicitors. The Subscriber
acknowledges that if the funds are advanced to the Company’s solicitors, the
solicitors shall release such funds to the Company on confirmation by the
Company that it will accept the subscription.

2.4      Loan Pending Closing.
Pending acceptance by the Company of the subscription for the Units, all funds
paid by the Subscriber on account of the Subscription Price shall be deposited
by the Company and immediately available to the Company for its corporate
purposes. In the event the Closing is not completed, the subscription funds will
constitute a non-interest bearing demand loan of the Subscriber to the
Company.

2.5      Delivery of
Certificates. The Subscriber hereby authorizes and directs the Company to
deliver the securities to be issued to such Subscriber pursuant to this
Agreement to the Subscriber’s address indicated on the signature page of this
Agreement.

2.6      No Minimum
Subscription. The Subscriber acknowledges and agrees that the subscription
for the Shares and the Company’s acceptance of the subscription is not subject
to any minimum subscription for the Offering.

2.7      Compliance with Securities
Laws. Any acceptance by the Company of the Subscription is conditional upon
compliance with all securities laws and other applicable laws of the
jurisdiction in which the Subscriber is resident. Each Subscriber will deliver
to the Company all other documentation, agreements, representations and
requisite government forms required by the lawyers for the Company as required
to comply with all securities laws and other applicable laws of the jurisdiction
of the Subscriber.

ARTICLE 3
AGREEMENTS, REPRESENTATIONS AND
WARRANTIES OF THE SUBSCRIBER

3.1      Exemption from
Registration. The Subscriber acknowledges and agrees that the Securities
will be offered and sold to the Subscriber without such offers and sales being
registered under the Securities Act and will be issued to the Subscriber in an
offshore transaction outside of the United States in accordance with a safe
harbour from the registration requirements of the Securities Act provided by
Rule 903 of Regulation S of the Securities Act based on the representations and
warranties of the Subscriber in this Agreement. As such, the Subscriber further
acknowledges and agrees that all Securities will, upon issuance, be “restricted
securities” within the meaning of the Securities Act.

- 4 -

3.2      Resales of Securities.
The Subscriber acknowledges that that the Securities may not be offered,
resold, pledged or otherwise transferred except through an exemption from
registration under the Securities Act or pursuant to an effective registration
statement under the Securities Act and in accordance with all applicable state
securities laws and the laws of any other jurisdiction. The Subscriber agrees to
resell the Securities only in accordance with the provisions of Regulation S of
the Securities Act, pursuant to registration under the Securities Act, or
pursuant to an available exemption from registration pursuant to the Securities
Act. The Subscriber agrees that the Company will refuse to register any transfer
of the Securities not made in accordance with the provisions of Regulation S of
the Securities Act, pursuant to registration under the Securities Act, pursuant
to an available exemption from registration. The Subscriber agrees that the
Company may require the opinion of legal counsel reasonably acceptable to the
Company in the event of any offer, sale, pledge or transfer of any of the
Securities by the Subscriber pursuant to an exemption from registration under
the Securities Act. 

3.3      Registration Rights.
The Company agrees to (i) file a registration statement with the SEC under the
Securities Act in order to register the resale by the Subscriber of the Shares
and the Warrant Shares within ninety (90) days of the date of Closing, and (ii)
use its best efforts to pursue the effectiveness of the registration statement
as early as possible.

3.4      Hedging Transactions.
The Subscriber agrees not to engage in hedging transactions with regard to the
Securities unless in compliance with the Securities Act.

3.5      Share Certificates.
  The Subscriber acknowledges and agrees that all certificates representing the
  Shares and Warrant Shares will be endorsed with the following legend, or such
  similar legend as deemed advisable by legal counsel for the Company, to ensure
  compliance with Regulation S of the Securities Act and to reflect the status
  of the Shares and Warrant Shares as restricted securities:

  “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE
    NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT"),
    AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION
    REQUIREMENTS OF THE ACT PROVIDED BY REGULATION S PROMULGATED UNDER
    THE ACT. SUCH SECURITIES MAY NOT BE REOFFERED FOR SALE OR RESOLD
    OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE
    WITH THE PROVISIONS OF REGULATION S, PURSUANT TO AN EFFECTIVE REGISTRATION
    UNDER THE ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION
    UNDER THE ACT. HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT
    BE CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT.”

3.6      Warrant Exercises. The
Subscriber acknowledge and agree that the Warrants may only be exercised (i)
outside the United States in an offshore transaction in accordance with Rule 903
of Regulation S, or (ii) within the United States pursuant to exemption from the
registration requirements of the Securities Act. In order to establish the
availability of Rule 903, the Subscriber acknowledges and agrees that it will
not be entitled to exercise the Warrants unless at the time of such exercise the
Subscriber is able to make the representations and warranties with respect its
purchase of the Warrant Shares set forth in the exercise form attached to the
certificate representing the Warrants. If the Warrants are to be exercised
pursuant to an exemption from the registration requirements of the Securities
Act, the Subscriber will be required to deliver a legal opinion in form and
substance satisfactory to the Company to the effect that the Warrant Shares may
be issued pursuant to an exemption from the registration requirements of the
Securities Act.

- 5 -

3.7      Warrant Certificates.
The Subscriber acknowledges and agrees that certificates representing the
Warrants will be in the form attached hereto as Schedule B. The Subscriber
further acknowledges and agrees that all certificates representing the Warrants
will be endorsed with the following legend, or such similar legend as deemed
advisable by legal counsel for the Corporation, to ensure compliance with Rule
903 of Regulation S of the Securities Act and to reflect the status of the
Warrants as restricted securities:

  “THIS WARRANT AND THE SHARES TO BE ISSUED UPON ITS
    EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT"),
    AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS
    OF THE ACT PROVIDED BY REGULATION S PROMULGATED UNDER THE ACT. SUCH SECURITIES
    MAY NOT BE REOFFERED FOR SALE OR RESOLD OR OTHERWISE TRANSFERRED EXCEPT IN
    ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO AN EFFECTIVE REGISTRATION
    UNDER THE ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER
    THE ACT. THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR ON
    BEHALF OF A PERSON IN THE UNITED STATES OR A U.S. PERSON UNLESS THE WARRANT
    AND THE UNDERLYING SHARES AND WARRANTS HAVE BEEN REGISTERED UNDER THE SECURITIES
    ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH STATE OR AN EXEMPTION
    FROM SUCH REGISTRATION REQUIREMENTS IS AVAILABLE. "UNITED STATES" AND "U.S.
    PERSON" ARE AS DEFINED BY REGULATION S UNDER THE SECURITIES ACT. HEDGING TRANSACTIONS
    INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE
    ACT.”

3.8      Representations and
Warranties of the Subscriber. The Subscriber, represents and warrants to the
Company as follows, and acknowledges that the Company is relying upon such
covenants, representations and warranties in connection with the sale of the
Securities to the Subscriber:

(a)      The
Subscriber is not a “U.S. Person” as defined by Regulation S of the Securities
Act, as set forth in Schedule A of this Agreement.

(b)      The
Subscriber is not acquiring the Securities for the account or benefit of a U.S.
Person.

(c)      The
Subscriber was not in the United States at the time the offer to purchase the
Securities was received or at the time this Agreement was executed.

(d)      The
Subscriber has such knowledge, sophistication and experience in business and
financial matters such that it is capable of evaluating the merits and risks of
the investment in the Securities. The Subscriber has evaluated the merits and
risks of an investment in the Securities. The Subscriber can bear the economic
risk of this investment, and is able to afford a complete loss of this
investment.

(e)      The
Subscriber acknowledges that the Company is in the early stages of development
of its business and the Company’s success is subject to a number of significant
risks, including the risk that the Company will not be able to finance its plan
of operations and that the Company’s 

- 6 -

business plan will not succeed. The
Subscriber acknowledges that any forward-looking information provided by the
Company to the Subscriber are subject to risks and uncertainties and that the
Company’s actual results may differ materially from the results anticipated.

(f)      The
Securities will be acquired by the Subscriber for investment for the
Subscriber's own account, not as a nominee or agent, and not with a view to the
resale or distribution of any part thereof, and that the Subscriber has no
present intention of selling, granting any participation in, or otherwise
distributing the same. The Subscriber does not have any contract, undertaking,
agreement or arrangement with any person to sell, transfer or grant
participations to such person or to any third person, with respect to any of the
Securities.

(g)      The
Subscriber has received or has had full opportunity to review the Company’s
filing with the SEC under the Exchange Act (the “Company’s SEC Filings”). The
Subscriber has had full opportunity to ask questions and receive answers from
representatives of the Company regarding the Company’s SEC Filings, the terms
and conditions of the Offering and the business, properties, prospects and
financial condition of the Company, each as is necessary to evaluate the merits
and risks of investing in the Securities. The Subscriber believes it has
received all the information it considers necessary or appropriate for deciding
whether to purchase the Securities. The Subscriber has had full opportunity to
discuss this information with the Subscriber’s legal and financial advisers
prior to execution of this Agreement.

(h)      The
Subscriber represents that it is familiar with SEC Rule 144, as presently in
effect, and understands the resale limitations imposed thereby and by the
Securities Act.

(i)      The
Subscriber has satisfied himself or herself as to the full observance of the
laws of his or her jurisdiction in connection with any invitation to subscribe
for the Securities or any use of this Agreement, including (i) the legal
requirements within his jurisdiction for the purchase of the Securities; (ii)
any foreign exchange restrictions applicable to such purchase; (iii) any
governmental or other consents that may need to be obtained; (iv) the income tax
and other tax consequences, if any, that may be relevant to an investment in the
Securities; and (v) any restrictions on transfer applicable to any disposition
of the Securities imposed by the jurisdiction in which the Subscriber is
resident.

(j)      The
Subscriber has not purchased the Securities as a result of any form of general
solicitation or general advertising, including advertisements, articles, notices
or other communications published in any newspaper, magazine or similar media or
broadcast over radio, television or other form of telecommunications, or any
seminar or meeting whose attendees have been invited by general solicitation or
general advertising.

(k)      This
Agreement has been duly authorized, validly executed and delivered by the
Subscriber.

ARTICLE 4
REPRESENTATIONS AND WARRANTIES OF THE
COMPANY

     4.1     
Representations and Warranties of the Company. The Company represents and
warrants to the Subscriber and acknowledges that the Subscriber is relying upon
such representations and warranties in connection with the execution, delivery
and performance of this Agreement:

- 7 -

(a)      The
Company is a corporation duly incorporated and in good standing under the laws
of the State of Nevada, and has the requisite corporate power and authority to
conduct its business as it is currently being conducted, to enter into this
Agreement and to sell the Securities to the Subscriber.

(b)      The
execution and delivery by the Company of this Agreement has been duly authorized
by all necessary action on the part of the Company, and no further consent or
action is required by the Company, its board of directors or its
stockholders.

(c)      The
issuance of the Securities has been duly authorized by all necessary corporate
action of the Company.

(d)      The
issuance of the Shares and the Warrants has been duly authorized and, when
issued upon payment thereof in accordance with this Agreement, will have been
validly issued, fully paid and non-assessable. The Warrant Shares have been
authorized and validly reserved for issuance, and when issued upon exercise of
the Warrant in accordance with the terms thereof (and upon payment of the
exercise price therefor), will be validly issued, fully paid and non-assessable.

(e)      The
existing stockholders of the Company have no pre-emptive or similar rights to
purchase shares of Common Stock from the Company.

(f)      The
issue and sale of the Securities by the Company does not and will not conflict
with, and does not and will not result in a breach of, any of the terms of its
Articles of Incorporation or Bylaws or any agreement or instrument to which the
Company is a party.

ARTICLE 5
MISCELLANEOUS PROVISIONS

5.1      Effectiveness of
Representations; Survival. Each party is entitled to rely on the
representations, warranties and agreements of each of the other parties and all
such representation, warranties and agreement will be effective regardless of
any investigation that any party has undertaken or failed to undertake. The
representation, warranties and agreements will survive the purchase and sale of
the Securities.

5.2      Further Assurances.
Each of the parties hereto will cooperate with the others and execute and
deliver to the other parties hereto such other instruments and documents and
take such other actions as may be reasonably requested from time to time by any
other party hereto as necessary to carry out, evidence, and confirm the intended
purposes of this Agreement.

5.3      Amendment. This
Agreement may not be amended except by an instrument in writing signed by each
of the parties.

5.4      Expenses. Each party
to this Agreement will bear its respective expenses incurred in connection with
the preparation, execution, and performance of this Agreement and the
transactions contemplated hereby, including all fees and expenses of agents,
representatives, counsel, and accountants. 

5.5      Entire Agreement. This
Agreement constitutes the entire agreement between the parties with respect to
the subject matter hereof and supersede all prior arrangements and
understandings, both 

- 8 -

written and oral, expressed or implied, with respect thereto.
Any preceding correspondence or offers are expressly superseded and terminated
by this Agreement.

5.6      Severability. If one
or more provisions of this Agreement is held to be unenforceable under
applicable law, such provision will be excluded from this Agreement and the
balance of this Agreement will be enforceable in accordance with its
terms.
Notices. All notices and other communications required or
permitted under to this Agreement must be in writing and will be deemed given if
sent by personal delivery, faxed with electronic confirmation of delivery,
internationally-recognized express courier or registered or certified mail
(return receipt requested), postage prepaid. All such notices and other
communications will be deemed to have been received (a) in the case of personal
delivery, on the date of such delivery, (b) in the case of a fax, when the party
sending such fax has received electronic confirmation of its delivery, (c) in
the case of delivery by internationally-recognized express courier, on the
business day following dispatch and (d) in the case of mailing, on the fifth
business day following mailing.

5.7      Headings. The headings
contained in this Agreement are for convenience purposes only and will not
affect in any way the meaning or interpretation of this Agreement.

5.8      Benefits. This
Agreement is and will only be construed as for the benefit of or enforceable by
those persons party to this Agreement.

5.9      Assignment. This
Agreement may not be assigned (except by operation of law) by any party without
the consent of the other parties.

5.10      Governing Law. This
Agreement will be governed by and construed in accordance with the laws of the
State of Nevada applicable to contracts made and to be performed therein. 

5.11      Construction. The
language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rule of strict construction will
be applied against any party. 

5.12      Electronic Means.
Delivery of an executed copy of this Agreement by electronic facsimile
transmission or other means of electronic communication capable of producing a
printed copy will be deemed to be execution and delivery of this Agreement as of
the date of its acceptance by the Company.

5.13      Schedules and
Exhibits. The schedules and exhibits are attached to this Agreement and
incorporated herein.

5.14      Counterparts. This
Agreement may be executed in one or more counterparts, all of which will be
considered one and the same agreement and will become effective when one or more
counterparts have been signed by each of the parties and delivered to the other
parties, it being understood that all parties need not sign the same
counterpart.

- 9 -

IN WITNESS WHEREOF, this Subscription Agreement is
executed as of the day and year first written above.

	Number of Units Subscribed for: 	 
    
	 	 
	Subscription Price (per Unit): 	$0.125 per Unit 
	 	 
	Total Subscription Price (US$): 	 
    
	 	 
	Signature of Subscriber or Authorized Signatory of
      Subscriber: 	
	 	 
	Name of Authorized Signatory of Subscriber (if
      applicable): 	
	 	 
	Title of Authorized Signatory of 	 
    
	 	 
	Subscriber (if applicable): 	 
    
	 	 
	Name of Subscriber: 	 
    
	 	 
	Address of Subscriber: 	 
    
	 	 
	  	  
	ACCEPTED BY: 	  
	 	 
	NEXTGENBIOSCIENCE INC. 	  
	 	 
	Signature of Authorized Signatory: 	 
    
	 	 
	Name of Authorized Signatory: 	 
    
	 	 
	Position of Authorized Signatory: 	 
    
	 	 
	Date of Acceptance: 	 
    

- 10 -

SCHEDULE A

DEFINITION OF U.S. PERSON

A “U.S. Person” is defined by Regulation S of the Act to be any
person who is:

	 	(a) 	
      any natural person resident in the United
  States;

	 	 	 	 
	 	(b) 	
      any partnership or corporation organized or incorporated
      under the laws of the United States;

	 	 	 	 
	 	(c) 	
      any estate of which any executor or administrator is a
      U.S. person;

	 	 	 	 
	 	(d) 	
      any trust of which any trustee is a U.S.
person;

	 	 	 	 
	 	(e) 	
      any agency or branch of a foreign entity located in the
      United States;

	 	 	 	 
	 	(f) 	
      any non-discretionary account or similar account (other
      than an estate or trust) held by a dealer or other fiduciary organized,
      incorporate, or (if an individual) resident in the United States;
    and

	 	 	 	 
	 	(g) 	
      any partnership or corporation if:

	 	 	 	 
	 		(i) 	
      organized or incorporated under the laws of any foreign
      jurisdiction; and

	 	 	 	 
	 		(ii) 	
      formed by a U.S. person principally for the purpose of
      investing in securities not registered under the Act, unless it is
      organized or incorporated, and owned, by accredited Subscribers [as
      defined in Section 230.501(a) of the Act] who are not natural persons,
      estates or trusts.

- 11 -

SCHEDULE B

FORM OF WARRANT

- 12 -

  THIS WARRANT AND THE SHARES TO BE ISSUED UPON ITS EXERCISE
    HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT"), AND
    HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS
    OF THE ACT PROVIDED BY REGULATION S PROMULGATED UNDER THE ACT. SUCH SECURITIES
    MAY NOT BE REOFFERED FOR SALE OR RESOLD OR OTHERWISE TRANSFERRED EXCEPT IN
    ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO AN EFFECTIVE REGISTRATION
    UNDER THE ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER
    THE ACT. THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR ON
    BEHALF OF A PERSON IN THE UNITED STATES OR A U.S. PERSON UNLESS THE WARRANT
    AND THE UNDERLYING SHARES AND WARRANTS HAVE BEEN REGISTERED UNDER THE SECURITIES
    ACT AND THE APPLICABLE SECURITIES LEGISLATION OF ANY SUCH STATE OR AN EXEMPTION
    FROM SUCH REGISTRATION REQUIREMENTS IS AVAILABLE. "UNITED STATES" AND "U.S.
    PERSON" ARE AS DEFINED BY REGULATION S UNDER THE SECURITIES ACT. HEDGING TRANSACTIONS
    INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE
    ACT.

NEXTGEN BIOSCIENCE INC.
A
NEVADA CORPORATION (the “Company”)

COMMON STOCK PURCHASE WARRANT CERTIFICATE

DATE OF ISSUANCE:

Warrant Certificate No. S-

	Name of Holder: 	  
	Address of Holder: 	  
	Number of Shares: 	  
	Exercise Price: 	US$0.25 per Share for a period of two years
      from the date of issuance until the Expiry Date 
	Expiry Date: 	  

THIS WARRANT CERTIFIES THAT, for value received, the
above named holder or its registered assigns (the “Holder”), shall have the
right to purchase from the Company the above referenced number of fully paid and
non-assessable shares (the “Shares”) of the Company’s common stock (the “Common
Stock”) at an exercise price equal to the exercise price set forth above (the
"Exercise Price"), subject to further adjustment as set forth in this
Certificate, at any time from the date hereof until 5:00 P.M., Pacific time, on
the expiry date set forth above (the “Expiry Date”). This Warrant is issued
pursuant to the Subscription Agreement between the Company and Holder (the
“Subscription Agreement”) pursuant to which the Holder purchased units
consisting of one share of Common Stock and one warrant to purchase one
additional share of Common Stock. The exercise of this Warrant shall be subject
to the provisions, limitations and restrictions contained herein. 

- 13 -

1.     
Exercise. 

     1.1     
Procedure for Exercise of Warrant. The Holder may exercise this Warrant
by delivering the following to the principal office of the Company in accordance
with Section 5.1 hereof:

	 	(a) 	
      a duly executed Notice of Exercise in substantially the
      form attached as Schedule A,

	 	 	 
	 	(b) 	
      either (i) a written certification that the Holder is not
      a U.S. person, as defined under Regulation S of the Securities Act, and
      that the Warrant is not being exercised on behalf of a U.S. person, which
      written certificate may be contained in the Notice of Exercise delivered
      pursuant to sub-paragraph (a) above; or (ii) a written opinion of counsel
      to the effect that the Warrant and the Shares have been registered under
      the Securities Act or are exempt from registration thereunder;

	 	 	 
	 	(c) 	
      payment of the Exercise Price then in effect for each of
      the Shares being purchased, as designated in the Notice of Exercise,
      and

	 	 	 
	 	(d) 	
      this Warrant.

Payment of the Exercise Price may be in cash, certified or
official bank check payable to the order of the Company, or wire transfer of
funds to the Company’s account (or any combination of any of the foregoing) in
the amount of the Exercise Price for each share being purchased. 

     1.2     
Delivery of Certificate and New Warrant. In the event of any exercise of
the rights represented by this Warrant, a certificate or certificates for the
shares of Common Stock so purchased, registered in the name of the Holder,
together with any other securities or other property which the Holder is
entitled to receive upon exercise of this Warrant, shall be delivered to the
Holder hereof, at the Company’s expense, within a reasonable time, not exceeding
thirty (30) calendar days, after the rights represented by this Warrant shall
have been so exercised; and, unless this Warrant has expired, a new Warrant
representing the number of Shares (except a remaining fractional share), if any,
with respect to which this Warrant shall not then have been exercised shall also
be issued to the Holder hereof within such time. The person in whose name any
certificate for shares of Common Stock is issued upon exercise of this Warrant
shall for all purposes be deemed to have become the holder of record of such
shares on the date on which the Warrant was surrendered and payment of the
Exercise Price was received by the Company, irrespective of the date of delivery
of such certificate. 

     1.3     
Restrictive Legend. This Warrant and the Shares have not been registered
under the Securities Act of 1933, as amended, (the "Securities Act") and the
Warrants have been and the Shares, upon exercise of the Warrants, will be issued
pursuant to exemptions from the registration requirements of the Securities Act.
Neither this Warrant nor any of the Shares or any other security issued or
issuable upon exercise of this Warrant may be sold, transferred, pledged or
hypothecated in the absence of an effective registration statement under the Act
relating to such security or an exemption from the registration requirements of
the Securities Act. Each certificate for the Warrant, the Shares and any other
security issued or issuable upon exercise of this Warrant shall contain a legend
on the face thereof, in form and substance satisfactory to counsel for the
Company, setting forth the restrictions on transfer contained in this Section.
The Holder understands that this Warrant constitutes and the Shares upon
issuance will constitute “restricted securities” under the Securities Act. The
holder acknowledges and agrees that all certificates representing the Shares
will be endorsed with the following legend:

  “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE
    NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT"), AND HAVE
    

- 14 -

  BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION
    REQUIREMENTS OF THE ACT PROVIDED BY REGULATION S PROMULGATED UNDER THE ACT.
    SUCH SECURITIES MAY NOT BE REOFFERED FOR SALE OR RESOLD OR OTHERWISE TRANSFERRED
    EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO AN EFFECTIVE
    REGISTRATION UNDER THE ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION
    UNDER THE ACT. HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED
    UNLESS IN COMPLIANCE WITH THE ACT.”

     1.4     
Fractional Shares. No fractional Shares shall be issuable upon exercise
or conversion of the Warrant and the number of Shares to be issued shall be
rounded down to the nearest whole Share. If a fractional share interest arises
upon any exercise or conversion of the Warrant, the Company shall eliminate such
fractional share interest by paying to Holder an amount computed by multiplying
the fractional interest by the current market price of a full Share. 

2.     
Covenants of the Company.

     2.1     
Authorized Shares. The Company covenants and agrees that the
Company will at all times have authorized and reserved, free from preemptive
rights, a sufficient number of shares of Common Stock to provide for the
exercise in full of the rights represented by this Warrant.

     2.2     
Issuance of Shares. The Company covenants and agrees that all
shares of Common Stock that may be issued upon the exercise of the rights
represented by this Warrant will, upon issuance, be validly issued, fully paid
and non-assessable, and free from all transfer taxes, liens and charges with
respect to the issue thereof. 

3.     
Transfer and Replacement. 

     (a)     
Subject to compliance with any applicable securities laws and the conditions set
forth herein, this Warrant and all rights hereunder are transferable, in whole
or in part, upon surrender of this Warrant at the principal office of the
Company, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and
funds sufficient to pay any transfer taxes payable upon the making of such
transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or
assignees and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the
portion of this Warrant not so assigned, and this Warrant shall promptly be
cancelled. A Warrant, if properly assigned, may be exercised by a new holder for
the purchase of Shares without having a new Warrant issued. 

     (b)     
The Company agrees to maintain, at its aforesaid office, books for the
registration and the registration of transfer of the Warrants.

     (c)     
If, at the time of the surrender of this Warrant in connection with any transfer
of this Warrant, the transfer of this Warrant shall not be registered pursuant
to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws, the Company may require, as a
condition of allowing such transfer that (i) the Holder or transferee of this
Warrant, as the case may be, furnish to the Company a written opinion of counsel
(which opinion shall be in form, substance and scope customary for opinions of
counsel in comparable transactions) to the effect that such transfer may be made
without registration under the Securities Act and under applicable state
securities or blue sky laws, and (ii) that the holder or transferee execute and
deliver to the Company such documentation as is 

- 15 -

necessary to establish that the shares are being transferred
pursuant to an exemption from the registration requirements of the Securities
Act and applicable state securities laws or in an offshore transaction pursuant
to and in accordance with Rule 904 of Regulation S of the Securities Act.

     (d)     
The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
or any stock certificate relating to the Shares, and in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory to it (which, in
the case of the Warrant, shall not include the posting of any bond), and upon
surrender and cancellation of such Warrant or stock certificate, if mutilated,
the Company will make and deliver a new Warrant or stock certificate of like
tenor and dated as of such cancellation, in lieu of such Warrant or stock
certificate.

4.     
Adjustments of Exercise Price and/or Number of Shares. 

     4.1     
Subdivision or Combination of Shares. The number and kind of securities
purchasable upon the exercise of this Warrant and the Exercise Price shall be
subject to adjustment from time to time upon the happening of any of the
following. In case the Company shall (i) pay a dividend in shares of Common
Stock or make a distribution in shares of Common Stock to holders of its
outstanding Common Stock, (ii) subdivide its outstanding shares of Common Stock
into a greater number of shares, (iii) combine its outstanding shares of Common
Stock into a smaller number of shares of Common Stock, or (iv) issue any shares
of its capital stock in a reclassification of the Common Stock, then the number
of Shares purchasable upon exercise of this Warrant immediately prior thereto
shall be adjusted so that the Holder shall be entitled to receive the kind and
number of Shares or other securities of the Company which it would have owned or
have been entitled to receive had such Warrant been exercised in advance
thereof. Upon each such adjustment of the kind and number of Shares or other
securities of the Company which are purchasable hereunder, the Holder shall
thereafter be entitled to purchase the number of Shares or other securities
resulting from such adjustment at an Exercise Price per Warrant Share or other
security obtained by multiplying the Exercise Price in effect immediately prior
to such adjustment by the number of Shares purchasable pursuant hereto
immediately prior to such adjustment and dividing by the number of Shares or
other securities of the Company resulting from such adjustment. An adjustment
made pursuant to this paragraph shall become effective immediately after the
effective date of such event retroactive to the record date, if any, for such
event.

     4.2     
Reorganization, Reclassification, Consolidation, Merger or Sale.
If any recapitalization, reclassification or reorganization of the share
capital of the Company, or any consolidation or merger of the Company with
another Company, or the sale of all or substantially all of its shares and/or
assets or other transaction (including, without limitation, a sale of
substantially all of its assets followed by a liquidation) shall be effected in
such a way that holders of Common Stock shall be entitled to receive shares,
securities or other assets or property, then, as a condition of such
recapitalizations, reclassifications, reorganizations, consolidations, mergers
or sales, lawful and adequate provisions shall be made by the Company whereby
the Holder hereof shall thereafter have the right to purchase and receive (in
lieu of the Common Stock of the Company immediately theretofore purchasable and
receivable upon the exercise of the rights represented hereby) such shares,
securities or other assets or property as may be issued or payable with respect
to or in exchange for the number of outstanding Common Stock which such Holder
would have been entitled to receive had such Holder exercised this Warrant
immediately prior to the consummation of such recapitalizations,
reclassifications, reorganizations, consolidations, mergers or sales. The
Company or its successor shall promptly issue to Holder a new Warrant for such
new securities or other property. The new Warrant shall provide for adjustments
which shall be as nearly equivalent as may be practicable to give effect to the
adjustments provided for in this Section 4 including, without limitation,
adjustments to the Exercise Price and to the number of securities or property
issuable upon exercise of the new Warrant. The provisions of this 

- 16 -

Section 4.2 shall similarly apply to successive
recapitalizations, reclassifications, reorganizations, consolidations, mergers
or sales. 

     4.3     
Notice of Adjustment. Whenever the number of Shares or number or
kind of securities or other property purchasable upon the exercise of this
Warrant or the Exercise Price is adjusted, as herein provided, the Company shall
give notice thereof to the Holder, which notice shall state the number of Shares
(and other securities or property) purchasable upon the exercise of this Warrant
and the Exercise Price of such Shares (and other securities or property) after
such adjustment, setting forth a brief statement of the facts requiring such
adjustment and setting forth the computation by which such adjustment was
made.

5.     
Miscellaneous Provisions. 

     5.1     
Notices. Any notice or other document required or permitted to be given
or delivered to the Holder shall be delivered or forwarded to the Holder at the
address for Holder provide on the first page of this Warrant or to such other
address or number as shall have been furnished to the Company in writing by the
Holder. Any notice or other document required or permitted to be given or
delivered to the Company shall be delivered or forwarded to the Company at the
address or number as shall have been furnished to Holder in writing by the
Company. All notices, requests and approvals required by this Warrant shall be
in writing and shall be conclusively deemed to be given (a) when hand-delivered
to the other party, (b) when received if sent by facsimile at the address and
number set forth above; provided that notices given by facsimile shall not be
effective, unless either (i) a duplicate copy of such facsimile notice is
promptly given by depositing the same in the mail, postage prepaid and addressed
to the party as set forth below or (ii) the receiving party delivers a written
confirmation of receipt for such notice by any other method permitted under this
paragraph; and further provided that any notice given by facsimile received
after 5:00 p.m. (recipient’s time) or on a non-business day shall be deemed
received on the next business day; (c) five (5) business days after deposit in
the United States mail, certified, return receipt requested, postage prepaid,
and addressed to the party as set forth below; or (d) the next business day
after deposit with an international overnight delivery service, postage prepaid,
addressed to the party as set forth below with next business day delivery
guaranteed; provided that the sending party receives confirmation of delivery
from the delivery service provider. 

     5.2     
Limitation of Liability. No provision hereof, in the absence of
affirmative action by the Holder to purchase shares of Common Stock, and no mere
enumeration herein of the rights or privileges of the Holder, shall give rise to
any liability of the Holder for the Exercise Price hereunder or as a stockholder
of the Company, whether such liability is asserted by the Company or by
creditors of the Company. 

     5.3     
No Rights as Stockholder. This Warrant shall not entitle the Holder to
any of the rights of a stockholder of the Company except upon exercise in
accordance with the terms hereof.

     5.4     
Governing Law. This Warrant shall be governed by and construed in
accordance with the laws of the State of Nevada as applied to agreements among
Nevada residents made and to be performed entirely within the State of Nevada,
without giving effect to the conflict of law principles thereof. 

     5.5     
Waiver, Amendments and Headings. This Warrant and any provision hereof
may be changed, waived, discharged or terminated only by an instrument in
writing signed by both parties (either generally or in a particular instance and
either retroactively or prospectively). The headings in this Warrant are for
purposes of reference only and shall not affect the meaning or construction of
any of the provisions hereof. 

- 17 -

IN WITNESS WHEREOF, the Company has caused this Warrant
to be signed by its duly authorized officer effective as of the 31st
day of January, 2008. 

		 NEXTGEN BIOSCIENCE
      INC. 
	 	 
		 Per: 
	 	 
	Signature of Authorized Signatory: 	 
	 	 
	Name of Authorized Signatory: 	 
	 	 
	Position of Authorized Signatory: 	 

SCHEDULE A 

FORM OF NOTICE OF EXERCISE 

TO: NEXTGEN BIOSCIENCE INC.

The undersigned hereby exercises the right to purchase the
number of shares of common stock of NextGen Bioscience Inc. (the "Company") set
forth below (the "Shares") pursuant to the Warrant to Purchase Common Stock
issued by the Company and dated 31st January 2008 In accordance with
the provisions of the Warrant, the undersigned hereby tenders the following
concurrently with the delivery of this Notice of Exercise (i) payment of the
Exercise Price payable by the undersigned for the Shares (the “Purchase Price”)
in effect for each of the Shares being purchased, and (ii) the original
Warrant.

	Number of Shares Purchased: 	Shares 
	 	 
	Aggregate Purchase Price: 	US$ 

The undersigned represents and warrants to and agrees with the
Company that:

	1. 	It has such knowledge and experience in financial
      and business matters as to be capable of evaluating the merits and risks
      of an investment in the Shares and it is able to bear the economic risk
      of loss of its entire investment. 
	  	  	  
	2. 	The Company has provided to it the opportunity to
      ask questions and receive answers concerning the terms and conditions of
      the offering and it has had access to such information concerning the Company
      as it has considered necessary or appropriate in connection with its investment
      decision to acquire the Shares. 
	  	  	  
	3. 	It is acquiring the Shares for its own account, for
      investment purposes only and not with a view to any resale, distribution
      or other disposition of the Shares in violation of the United States securities
      laws. 
	  	  	  
	4. 	It understands the Shares have not been and will
      not be registered under the United States Securities Act of 1933, as amended
      (the "1933 Act") or the securities laws of any state of the United States
      and that the sale contemplated hereby is being made in reliance on a safe-harbour
      from such registration requirements. 
	  	  	  
	5. 	The undersigned is not a “U.S. Person”
      as defined by Regulation S of the Securities Act and is not acquiring the
      Shares for the account or benefit of a U.S. Person. 
	  	  	  
	  	 A “U.S. Person” is defined
      by Regulation S of the Act to be any person who is: 
	  	  	  
	  	(h) 	any natural person resident in the United States; 
	  	  	  
		(i) 	any partnership or corporation organized or incorporated
      under the laws of the United States; 
	  	  	  
	  	(j) 	any estate of which any executor or administrator is a U.S.
      person; 

- 2 -

	 	(k) 	
      any trust of which any trustee is a U.S.
      person;

	 	 	 	 
	 	(l) 	
      any agency or branch of a foreign entity located in
      the United States;

	 	 	 	 
	 	(m) 	
      any non-discretionary account or similar account
      (other than an estate or trust) held by a dealer or other fiduciary
      organized, incorporate, or (if an individual) resident in the United
      States; and

	 	 	 	 
	 	(n) 	
      any partnership or corporation if:

	 	 	 	 
	 		(i) 	
      organized or incorporated under the laws of any
      foreign jurisdiction; and

	 	 	 	 
	 		(ii) 	
      formed by a U.S. person principally for the purpose of
      investing in securities not registered under the Act, unless it is
      organized or incorporated, and owned, by accredited Subscribers [as
      defined in Section 230.501(a) of the Act] who are not natural persons,
      estates or trusts.

	6. 	
      The undersigned was not in the United States at the time
      the offer to purchase the Shares was received and the Subscriber was not
      in the United States at the time these Warrants were exercised.

	 	 
	7. 	
      The undersigned acknowledges that the Shares are
      “restricted securities” within the meaning of the Securities Act and will
      be issued to the Subscriber in accordance with Regulation S of the
      Securities Act without registration under the Securities Act.

	 	 
	8. 	
      The undersigned agrees to resell the Shares only in
      accordance with the provisions of Regulation S of the Securities Act,
      pursuant to registration under the Securities Act, or pursuant to an
      available exemption from registration pursuant to the Securities
    Act.

	 	 
	9. 	
      The undersigned agrees not to engage in hedging
      transactions with regard to the Shares unless in compliance with the
      Securities Act.

	 	 
	10. 	
      The Subscriber acknowledges and agrees that all
      certificates representing the Shares will be endorsed with the following
      legend in accordance with Regulation S of the Securities
  Act:

  
    “THE SECURITIES REPRESENTED BY THIS CERTIFICATE
      HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT"), AND
      HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS
      OF THE ACT PROVIDED BY REGULATION S PROMULGATED UNDER THE ACT. SUCH SECURITIES
      MAY NOT BE REOFFERED FOR SALE OR RESOLD OR OTHERWISE TRANSFERRED EXCEPT
      IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO AN EFFECTIVE
      REGISTRATION UNDER THE ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION
      UNDER THE ACT. HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE
      CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT.”

  

- 3 -

	11. 	
      The Subscriber and the Company agree that the Company
      will refuse to register any transfer of the Shares not made in accordance
      with the provisions of Regulation S of the Securities Act, pursuant to
      registration under the Securities Act, pursuant to an available exemption
      from registration, or pursuant to this
Agreement.

	Date of Execution: 	 
	 	 
	Signature of Purchaser or Authorized Signatory of Purchaser
      (if the Purchaser is not an individual): 	
	 	 
	Name of Authorized Signatory of Purchaser(if the Purchaser
      is not an individual): 	
	 	 
	Title of Authorized Signatory of Purchaser(if the Purchaser
      is not an individual): 	
	 	 
	Name of Purchaser: 	 
	 	 
	Address of Purchaser:Filed by Automated Filing Services Inc. (604) 609-0244 - Nextgen Bio UK Limited - Exhibit 10.3

EXHIBIT 10.3

DATED 31ST JANUARY 2008

 

	 	NEXTGEN BIO UK LIMITED. 	(1) 	 
	 	 	 	 
	 	 	 	 
	 	and 	  	 
	 	 	 	 
	 	 	 	 
	 	DR. KAREN ELIZABETH JERVIS 	(2) 	 
	 	  	  	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	EMPLOYMENT AGREEMENT 	  	 
	 	 	 	 

DATE OF EMPLOYMENT AGREEMENT 31ST
JANUARY 2008

PARTIES

	(1) 	
      NEXTGEN BIO UK LIMITED, a company incorporated
      under the laws of England and Wales whose registered office is at 4th
      Floor, 36 Spital Square, London, E1 6DY, England (“the
      Company”).

	 	 
	(2) 	
      DR KAREN ELIZABETH JERVIS of 1 Bellfield Crescent,
      Eddleston, Peebles, EH45 8RQ (“the
Executive”).

WHEREAS the Board of Directors of the Company has
approved the terms of this Agreement under which the Executive is to be retained
to provide Employments.

IT IS AGREED as follows:

	1. 	
      DEFINITIONS

	 	 	 	 
		1.1 	
      In this Agreement the following words, phrases and
      expressions shall have the following meanings:

	 	 	 	 
			1.1.1 	
      "Board" means the Board of Directors of the
      Company from time to time and any such person or committee authorised by
      the Board as its representative for the purposes of this
  Agreement;

	 	 	 	 
			1.1.2 	
      “Chairman” means the Chairman of the Company for
      the time being;

	 	 	 	 
			1.1.3 	
      "Commencement Date" means 1st February
      2008 or such later date as may be mutually agreed between the
    parties;

	 	 	 	 
			1.1.4 	
      "Group Company" means the Company and its
      subsidiaries and any holding company of the Company and any subsidiary of
      such holding company and any associated company (which expression shall
      mean any other company of which the Company or its holding company or any
      subsidiary or the company or its holding company beneficially holds not
      less than 20% of the equity share capital);

	 	 	 	 
			1.1.5 	
      "Immediate Relatives" means husband, common law
      spouse, children, brothers, sisters, cousins, aunts, uncles, parents,
      grandparents, and the aforesaid relatives by marriage;

	 	 	 	 
			1.1.6 	
      "Termination Date" means the date upon which this
      Agreement is terminated (and references to "from the Termination
      Date" means from and including the date of such
termination);

	 	 	 	 
		1.2 	
      Any reference to a statutory provision includes all
      re-enactments and modifications of it or the provision referred to and any
      regulations made under it or under the provision referred
  to.

1

		1.3 	
      The headings in this Agreement have been inserted for
      convenience only and they do not form part of this Agreement and do not
      affect its interpretation or construction.

	 	 	 	 	 
		1.4 	
      Any reference to the Executive shall, if appropriate,
      include her personal representatives.

	 	 	 	 	 
	2. 	
      THE APPOINTMENT

	 	 	 	 	 
		2.1 	
      The Executive shall provide the services hereunder, and
      the Company shall from the Commencement Date, appoint the Executive, and
      the Executive shall act as Chief Executive Officer of a Group
    Company.

	 	 	 	 	 
		2.2 	
      The Executive shall provide the services as described
      hereunder to the fullest extent envisaged by this Agreement, but subject
      to non- availability due to incapacity as per Clause 13 and during
      holidays granted in accordance with the normal policy of the Company in
      force from time to time.

	 	 	 	 	 
	3. 	
      DURATION

	 	 	 	 	 
		3.1 	
      This Agreement shall, subject to termination in
      accordance with the terms of this Agreement, commence on the Commencement
      Date and shall continue until terminated in accordance with Clause
    17.

	 	 	 	 	 
	4. 	
      DUTIES

	 	 	 	 	 
		4.1 	
      The Executive:

	 	 	 	 	 
			4.1.1 	
      shall:

	 	 	 	 	 
				4.1.1.1 	
      carry out such duties and functions;

	 	 	 	 	 
				4.1.1.2 	
      exercise such powers; and

	 	 	 	 	 
				4.1.1.3 	
      comply with such instructions;

	 	 	 	 	 
				
      in connection with the business of the Company and the
      Group Companies as the Board reasonably determines from time to time;
      and

	 	 	 	 	 
			4.1.2 	
      shall comply with all the Company's reasonable rules,
      regulations, policies and procedures from time to time in force.

	 	 	 	 	 
		4.2 	
      Unless prevented by incapacity as per Clause 13 or
      holiday as set out below, the Executive will:

	 	 	 	 	 
			4.2.1 	
      devote sufficient of her time, attention and skill during
      her working hours under this Agreement insofar as may reasonably be
      required to the affairs of the Company; and

2

	 		4.2.2 	
      use her best endeavours to promote the interests of the
      Company at all times.

	 	 	 	 
	 	4.3 	
      The Executive acknowledges and agrees that she is at all
      times during this Agreement, including during any period of suspension or
      while she is on garden leave in accordance with clause 17.5, subject to
      duties of goodwill, trust, confidence, exclusive service in accordance
      with Clause 6, faith and fidelity to the Company which duties include,
      without limitation, the duty throughout the duration of this
    Agreement:

	 	 	 	 
	 		4.3.1 	
      not to compete with the Company or with any Group
      Company;

	 	 	 	 
	 		4.3.2 	
      not to make preparations (during such hours during which
      the Executive should be providing services under this Agreement) to
      compete with the Company or with any Group Company after this Agreement
      has terminated;

	 	 	 	 
	 		4.3.3 	
      not to solicit in competition with the Company or with
      any Group Company any customer or customers of the Company or of any Group
      Company;

	 	 	 	 
	 		4.3.4 	
      not to entertain invitations to provide services in a
      personal capacity from customers of the Company or of any Group Company
      where such invitations relate to services which could be provided by the
      Company or by any Group Company;

	 	 	 	 
	 		4.3.5 	
      not to offer employment to employees of the Company or of
      any Group Company (other than employment by the Company or by any Group
      Company); and

	 	 	 	 
	 		4.3.6 	
      not to copy or memorise confidential information or trade
      secrets of the Company or of any Group Company with a view to using or
      disclosing such information for a purpose other than for the benefit of
      the Company or of that Group Company.

	 	 	 	 
	 	4.4 	
      The Executive will at all times promptly give to the
      Board (in writing if requested) all information, explanations and
      assistance that the Board may reasonably require in connection
  with:

	 	 	 	 
	 		4.4.1 	
      the business or affairs of the Company and of the Group
      Companies; and

	 	 	 	 
	 		4.4.2 	
      her duties under this Agreement.

	 	 	 	 
	 	4.5 	
      The Executive will:

	 	 	 	 
	 		4.5.1 	
      report to the Chairman; and

	 	 	 	 
	 		4.5.2 	
      be directly responsible to the Board.

	 	 	 	 
	 	4.6 	
      The Executive shall not without the prior written consent
      of the Board:

3

	 	 	4.6.1	incur any capital expenditure in excess of such sums as may
      be authorised from time to time; or
			
			 	 
			4.6.2 	 enter into (on behalf of the Company or of
        any Group Company) any commitment, contract or arrangement:

	 	 	 	 	 
				4.6.2.1 	 otherwise than in the normal course of business; or

	 	 	 	 	 
				4.6.2.2 	 outside the scope of her normal duties; or

	 	 	 	 	 
				4.6.2.3 	 which may be reasonably considered to be of an unusual,
        onerous or long-term nature.

	 	 	 	 	 
	5. 	 NORMAL HOURS

	 	 	 	 	 
		5.1 	 The Executive shall conform to such hours
        of work as may from time to time reasonably be required of her as are
        consistent with this Agreement.

	 	 	 	 	 
		5.2 	 The Executive expressly acknowledges and affirms:

	 	 	 	 	 
			5.2.1 	 that she has control over the hours which
        she works; and

	 	 	 	 	 
			5.2.2 	 that her working time is not monitored or
        determined by the Company.

	 	 	 	 	 
	6. 	 OTHER INTERESTS

	 	 	 	 	 
		6.1 	 The Executive:

	 	 	 	 	 
			6.1.1 	 shall devote as much of her time to the Company
        during her working hours under this Agreement as is necessary to fulfil
        her duties hereunder; and

	 	 	 	 	 
			6.1.2 	 shall not (without the prior written consent
        of the Board) directly or indirectly either on her own account or on behalf
        of any other person, company, business entity or other organisation:

	 	 	 	 	 
				6.1.2.1 	 engage in; or

	 	 	 	 	 
				6.1.2.2 	 be concerned with; or

	 	 	 	 	 
				6.1.2.3 	 provide services to (whether as an employee, officer,
        director, agent, partner, consultant or otherwise) any other business
        or other activity which does or might reasonably be expected to affect
        the performance of her duties under this Agreement; or

	 	 	 	 	 
				6.1.2.4 	 accept any other engagement or public office;

	 	 	 	 	 
				 EXCEPT THAT the Executive may hold
        up to 8% (eight percent) of any securities in a company which is quoted
        on any

4

	 	 	 	recognised Stock Exchange and may take up and/or continue
      part time honorary positions as a Member of the Scottish Scientific
      Advisory Committee to the Scottish Government and as a Consultant to the
      Royal Zoological Society of Scotland.
	 	 	 	 
		6.2 	
      The Executive:

	 	 	 	 	 
			6.2.1 	
      confirms that to the best of her knowledge and belief she
      has fully disclosed to the Company in writing all circumstances in respect
      of which there is, or there might be, a conflict of interests
    between:

	 	 	 	 	 
				6.2.1.1 	
      the Company or any Group Company; and

	 	 	 	 	 
				6.2.1.2 	
      the Executive or her Immediate Relatives; and

	 	 	 	 	 
			6.2.2 	
      agrees fully to disclose to the Board any such
      circumstances which may arise during this Agreement.

	 	 	 	 	 
	7. 	
      PLACE OF WORK

	 	 	 	 	 
		7.1 	
      The parties agree that the Executive's place of work
      shall be, usually in Scotland, at her own home office but may be also
      occasionally in London, at such premises of which the Company has the use
      in London from time to time and, in particular, the Executive shall be
      required to attend the meetings of the Company’s Advisory Board either in
      London or mainland Europe or elsewhere as notified by the Board,
      reasonable notice being given to the Executive of such requirement to
      attend these meetings.

	 	 	 	 	 
		7.2 	
      In performance of the Executive’s duties under this
      Agreement, she may also be required to travel both throughout and outside
      the United Kingdom for the better performance of those duties.

	 	 	 	 	 
	8. 	
      REMUNERATION

	 	 	 	 	 
		8.1 	
      The Executive will receive a monthly fee ("Monthly
      Fee") which shall be paid to the Executive in equal monthly
      instalments in arrears on or before the last working day of each calendar
      month and shall be according to the following schedule:

	 	 	 	 	 
			8.1.1 	
      £3,750 per month from the Commencement Date to 30th
      April 2008:

			
       

			8.1.2 	
      £4,000 per month to 31st July 2008;

	 	 	 	 	 
			8.1.3 	
      £6,667 per month to 31st July 2009;

	 	 	 	 	 
			8.1.4 	
      £8,333 per month to 31st July
2010.

5

	9. 	
      EXPENSES

	 	 	 	 
	9.1 	
      It is acknowledged that under normal circumstances, the
      Company will pay all reasonable travelling, hotel and other expenses
      properly authorised by the Chairman (acting reasonably), such expenses
      which are incurred in or about the proper performance of the Executive’s
      duties and which shall be evidenced in such manner as the Company may
      reasonably expect from time to time, however in such instances where the
      Executive pays for the aforesaid expenses, she shall be entitled to be
      repaid in full on demand with the following Monthly Fee.

	 	 	 	 
	10. 	
      OTHER BENEFITS

	 	 	 	 
		10.1 	
      There are no other benefits given by the Company to the
      Executive.

	 	 	 	 
	11. 	
      PENSION

	 	 	 	 
		11.1 	
      There is no Company pension scheme in force.

	 	 	 	 
	12. 	
      HOLIDAYS

	 	 	 	 
		12.1 	
      The Company's holiday year runs from 1 January to 31
      December.

	 	 	 	 
		12.2 	
      The Executive will in addition to bank and public
      holidays be entitled to 25  working days' paid holiday in each
      holiday year.

	 	 	 	 
		12.3 	
      Holidays shall accrue on a pro rata basis throughout each
      holiday year.

	 	 	 	 
	13. 	
      INCAPACITY

	 	 	 	 
		13.1 	
      If the Executive is incapacitated from performing her
      duties under this Agreement the Executive will notify the Company as soon
      as possible and then keep the Company informed.

	 	 	 	 
		13.2 	
      If such incapacity continues for a period of eight
      working days or more the Executive will produce to the Company a medical
      certificate to cover the duration of such absence.

	 	 	 	 
		13.3 	
      The Executive must produce medical certificates to cover
      any further period of absence.

	 	 	 	 
		13.4 	
      For the avoidance of doubt the provisions of this clause
      13 will not prejudice or limit in any way the Company's right to terminate
      this Agreement pursuant to clauses 3 and 17 or otherwise pursuant to its
      terms.

	 	 	 	 
		13.5 	
      The Company may terminate the Agreement in accordance
      with clause 17.2.6  or by making a payment in lieu pursuant to clause
      17.5.

	 	 	 	 
	14. 	
      CONFIDENTIAL INFORMATION

6

	 	14.1 	
      The Executive acknowledges that she will be exposed to
      information about the Company's business and the businesses of Group
      Companies and that of the Company's and the Group Companies' suppliers and
      customers:

	 	 	 	 	 
	 		14.1.1 	
      which amounts to a trade secret, is confidential or is
      commercially sensitive;

	 	 	 	 	 
	 		14.1.2 	
      which may not be readily available:

	 	 	 	 	 
	 			14.1.2.1 	
      to others engaged in a similar business to that of the
      Company or of any of the Group Companies; or

	 	 	 	 	 
	 			14.1.2.2 	
      to the general public; and

	 	 	 	 	 
	 		14.1.3 	
      which if disclosed will be liable to cause significant
      harm to the Company or to such Group Companies.

	 	 	 	 	 
	 	14.2 	
      Such information (whether recorded in writing, on
      computer disc or in any other medium) is referred to in this clause 14 as
      "Confidential Information".

	 	 	 	 	 
	 	14.3 	
      The Executive has therefore agreed to accept the
      restrictions contained in this clause 14.

	 	 	 	 	 
	 	14.4 	
      The Executive will not either directly or indirectly
      during the term of this Agreement or after its termination without limit
      in time for her own purposes or for any purposes other than those of the
      Company or of any Group Company (for any reason and in any manner) use or
      divulge or communicate to any person, firm, company or organisation
      (except to those officials of the Company or any Group Company whose
      province it is to know the same) any secret or Confidential Information or
      information constituting a trade secret acquired or discovered by her in
      the course of her employment with the Company relating to the private
      affairs or business of the Company or of any Group Company or of their
      suppliers, customers, management or shareholders.

	 	 	 	 	 
	 	14.5 	
      The restrictions contained in this clause 14 do not apply
      to:

	 	 	 	 	 
	 		14.5.1 	
      any disclosure:

	 	 	 	 	 
	 			14.5.1.1 	
      authorised by the Board; or

	 	 	 	 	 
	 			14.5.1.2 	
      required in the ordinary and proper course of the
      provision of services hereunder; or

	 	 	 	 	 
	 			14.5.1.3 	
      required by order of any court of competent jurisdiction
      or by an appropriate regulatory authority; or

	 	 	 	 	 
	 			14.5.1.4 	
      otherwise required by law; or

7

	 	 	 	14.5.1.5	of information that was in the public domain at the time
      of disclosure to the Executive or which is subsequently put into the
      public domain by or with the authority of the Company.
	 	 	 	 
				
      14.5.1.6 
	of information which is acquired or developed by the
      Executive independently of her duties to the Company and not as a result
      of breach of confidence by her
	 	 	 	 
			14.5.2 	
      any information, or Confidential Information that the
      Executive can demonstrate was known to the Executive prior to the date of
      this Agreement.

	 	 	 	 
		14.6 	
      The Executive will not other than with the approval of
      the Chairman or of any Director of the Group Company to whom she
      reports:

	 	 	 	 
			14.6.1 	
      make or issue any press, radio or television statement;
      or

	 	 	 	 
			14.6.2 	
      publish or submit for publication any letter or article
      relating directly or indirectly to the business affairs of the Company or
      of Group Company.

	 	 	 	 
		14.7 	
      The provisions of this clause 14 are without prejudice to
      the duties and obligations of the Executive to be implied into this
      Agreement at common law.

	 	 	 	 
	15. 	
      INTELLECTUAL PROPERTY

	 	 	 	 
		15.1 	
      The Executive acknowledges that because of:

	 	 	 	 
			15.1.1 	
      the nature of the duties and services hereunder;
    and

	 	 	 	 
			15.1.2 	
      the particular responsibilities arising as a result of
      such duties;

	 	 	 	 
			
      she owes to the Company and to any of the Group Companies
      a special obligation to further the interests of the Company and of the
      Group Companies.

	 	 	 	 
		15.2 	
      The Executive shall promptly disclose to the Company any
      idea or invention created by her in the normal course of the provision of
      services under this Agreement.

	 	 	 	 
		15.3 	
      The Executive acknowledges that all trade marks,
      registered designs, design rights, copyright, database rights and other
      intellectual property rights (together, where registrable, with the right
      to apply for registration of the same, aside from those described in
      clause 15.2), whether in existence now or coming into existence at any
      time in the future, will, on creation in the normal course of the services
      under this Agreement, vest in and be the exclusive property of the Company
      or of any of the Group Companies which the Company may nominate and if
      required to do so (whether during or after the termination of this
      Agreement):

8

			15.3.1	the Executive shall execute all instruments and do all
      things necessary to vest ownership in the above rights in the Company as
      sole beneficial owner at the Company’s sole cost; and
	 	 	 	 
			15.3.2 	
      where the same does not automatically vest by any
      applicable law, the Executive shall immediately assign the same to the
      Company; and

	 	 	 	 
			15.4.3 	
      the Executive irrevocably agrees to waive all moral
      rights in respect of such materials or works.

	 	 	 	 
		15.4 	
      The Executive appoints the Company to be her attorney in
      her name and on her behalf:

	 	 	 	 
			15.4.1 	
      to execute any such instrument or do any such thing
      necessary for the purpose of giving to the Company or to its nominee the
      full benefit of the provisions of this clause 15; and

	 	 	 	 
			15.4.2 	
      to acknowledge in favour of any third party that a
      certificate in writing signed by any director or secretary of the Company
      that any instrument or act falls within the authority conferred shall be
      conclusive evidence that such is the case.

	 	 	 	 
		15.5 	
      Clauses 15.1, 15.2, 15.3, and 15.4 cannot be amended or
      varied other than by written agreement with the parties.

	 	 	 	 
	16. 	
      STATEMENTS

	 	 	 	 
		16.1 	
      The Executive shall not at any time knowingly make any
      untrue or misleading statement in relation to the Company or to any Group
      Company.

	 	 	 	 
		16.2 	
      The Executive shall not at any time after the termination
      of this Agreement represent herself as being in any way connected with or
      interested in the Company or with or in any of the Group Companies or with
      or in any of their respective businesses unless the particulars are
      specifically agreed in writing with the Company.

	 	 	 	 
	17. 	
      TERMINATION

	 	 	 	 
		17.1 	
      This agreement shall terminate on 31st July
      2010 and may be terminated at any time prior to that date:

	 	 	 	 
			17.1.1 	
      by the Company after giving to the Executive three
      months’ notice in writing; and

	 	 	 	 
			17.1.2 	
      by the Executive after giving to the Company three
      month’s notice in writing.

	 	 	 	 
		17.2 	
      The Company may terminate this Agreement immediately
      without notice in writing (even if the Company may have allowed any time
      to elapse or on a former occasion may not have enforced its rights
      under

9

	 		
      this clause 17) and without obligation to pay any
      compensation to the Executive if:

	 	 		
			
      17.2.1 
	
      after final written warning, without any reasonable
      cause, she neglects or refuses to perform all or any of her duties or
      obligations under this Agreement; or

	 	 		
			
      17.2.2 
	
      the Executive misconducts herself whether during or
      outside the course of her duties under this Agreement in such a way that
      the business, operation, interests or reputation of the Company or of any
      Group Company are or are likely to be materially prejudicially affected;
      or

	 	 	
       
	
       

			
      17.2.3 
	
      the Executive commits any criminal offence (including in
      particular any offence involving dishonesty or violence) other
  than:

	 	 	
       
	
       

	 			
      17.2.3.1 
	
      a summary motoring offence; or

	 	 	
       
	
       

	 			
      17.2.3.2 
	
      any other offence which does not in the reasonable
      opinion of the Board affect her position under this Agreement;
or

	 	 	
       
	
       

			
      17.2.4
	
      the Executive is convicted of an offence under any
      statutory enactment or regulation relating to insider dealing;
or

	 	 	
       
	
       

			
      17.2.5
	
      the Executive becomes bankrupt or makes or attempts to
      make any composition with creditors; or

	 	 	
       
	
       

	 		
      17.2.6
	
      the Executive becomes of unsound mind; or

	 	 	
       
	
       

			
      17.2.7 
	
      the Executive commits any act of gross misconduct during
      the course of her duties under this Agreement; or

	 	 	
       
	
       

			
      17.2.8 
	
      the Executive is guilty of any deliberate act of
      discrimination, harassment or victimisation on race, sex or disability
      grounds.

	 	 	
       
	
       

	 	17.3 	
      The Company shall have the right to suspend the Executive
      (subject to the continued payment of the Monthly Fee and the continued
      provision of the Executive’s benefits) pending any investigation into any
      potential dishonesty, gross misconduct or any other circumstances which
      may give rise to a right for the Company to terminate this Agreement
      pursuant to clause 17.2 above for such reasonable period as it takes to
      conduct such an investigation.

	 	 	
       
	
       

		17.4 	
      The Executive may terminate this Agreement with immediate
      effect if the business of the Company is conducted in such a manner so as
      to be incompatible with the Executive’s obligations as a chief executive
      of a  company.

	 	 	
       
	
       

	 	17.5 	
      During any period of notice, and provided that the
      Company continues to pay the Monthly Fee and to provide all benefits to
      which the

10

		  
	Executive is contractually entitled (or
        a sum in lieu of the value to her of such benefits) until the termination
        of this Agreement, the Company shall be entitled at its absolute discretion:

	 	  
	  
	  
	  

			
      17.5.1 
	 to require the Executive not to carry out
        her duties or to exercise her powers or responsibilities under this Agreement
        during the remaining period of the notice period (or any part of such
        period);

	 	  
	
       
	  
	  

			 17.5.2 
	 to require the Executive to resign immediately
        from any offices which she may hold in the Company or in any Group Company;

	 	  
	
       
	  
	  

			 17.5.3 
	 to require the Executive not to attend any
        premises of the Company or of any Group Company during the remaining period
        of this Agreement (or any part of such period);

	 	  
	
       
	  
	  

			 17.5.4 
	 to require the Executive not to make contact
        with any employees, agents, customers or clients of the Company or of
        any Group Company except as directed by the Company during the remaining
        period of her notice (or any part of such period);

	 	  
	
       
	  
	  

			 17.5.5 
	 to require the Executive to return to the
        Company all documents, computer discs and other property (including summaries,
        extracts or copies) belonging to the Company or to any Group Company or
        to its or their clients or customers; and

	 	  
	
       
	  
	  

			 17.5.6 
	 to require the Executive to work from her
        home and/or (insofar as it is reasonable) to carry out exceptional duties
        or special projects outside the normal scope of her duties and responsibilities.

	 	  
	  
	  
	  

		 17.6 
	 Where notice is served, whether by the Company
        or by the Executive, to terminate the Agreement the Company may at its
        absolute discretion, at any time during the period of notice:

	 	  
	  
	  
	  

			 17.6.1 
	 terminate the Agreement forthwith without
        thereby being in breach of this Agreement; and

	 	  
	  
	  
	  

			 17.6.2 
	 in full and final settlement of the Executive's
        contractual claims under this Agreement pay to the Executive an amount
        equal to:

	 	  
	  
	  
	  

				 17.6.2.1 
	 the Monthly Fee; and

	 	  
	  
	  
	  

				 17.6.2.2 
	 the capitalised value of the benefits to which the Executive
        is entitled;

	 	  
	  
	  
	  

				 under this Agreement for the remaining period
        of notice.

	 	  
	  
	  
	  

	18. 	 DEDUCTIONS

	 	  
	  
	  
	  

		 The Executive hereby authorises the Company
        at any time during the continuance of this Agreement and in any event
        on termination howsoever

11

		
      arising, to deduct from the Monthly Fee (which for this
      purpose includes payment in lieu of notice, commission, bonus, holiday pay
      and sick pay) all debts owed by the Executive to the Company or to any
      Group Company, including but without limitation:

	 	 	 	 
		18.1 	
      the balance outstanding of any loans (and interest where
      appropriate) advanced by the Company to the Executive;

	 	 	 	 
		18.2 	
      the cost of repairing any damage or loss to the Company's
      property caused by the Executive.

	 	 	 	 
	19. 	
      RECONSTRUCTION OF THE COMPANY

	 	 	 	 
		
      The Executive shall have no claim against the Company if
      this Agreement is terminated by reason of the liquidation of the Company
      for the purposes of amalgamation or reconstruction provided that the
      Executive is offered an equivalent agreement with any concern or
      undertaking resulting from such amalgamation or reconstruction on terms
      and conditions which, taken as a whole, are not less favourable than the
      terms of this Agreement.

	 	 	 	 
	20. 	
      DELIVERY OF DOCUMENTS AND PROPERTY

	 	 	 	 
		20.1 	
      On termination of this Agreement for any reason (or
      earlier if requested) the Executive will immediately deliver up to the
      Company all property (including but not limited to any documents and
      software, credit cards, keys and security passes) belonging to it or to
      any Group Company in the Executive’s possession or under her
    control.

	 	 	 	 
		20.2 	
      For the purposes of clause 20.1 documents and software
      include (but are not limited to) correspondence, diaries, address books,
      databases, files, reports, minutes, plans, records, documentation or any
      other medium for storing information.

	 	 	 	 
		20.3 	
      The Executive's obligations under this clause 20 include
      the return of all copies, drafts, reproductions, notes, extracts or
      summaries (however stored or made) of all documents and
software.

	 	 	 	 
		20.4 	
      The Company may withhold any monies then owing to the
      Executive in any respect pending her providing, if so requested, her
      written undertaking that she has complied with the obligations contained
      in this clause 20.

	 	 	 	 
	21. 	
      RESIGNATION AS DIRECTOR

	 	 	 	 
		21.1 	
      Without prejudice to clause 17.5.2 the Executive will on
      termination of this Agreement for any reason at the request of the Board
      promptly resign without claim for compensation:

	 	 	 	 
			21.1.1 	
      as a director or member of the advisory board of the
      Company; and

12

		
	 	
       
	
       
	
       

			
      21.1.2 
	
      from all trusteeships held by her of any pension scheme
      or other trusts established by the Company or by any Group Company or by
      any other company with which the Executive has had dealings as a
      consequence of her secondment with the Company.

	 	
       
	
       
	
       

		
      21.2 
	
      If the Executive fails to resign within seven days of
      such request, the Company is irrevocably authorised to appoint a person to
      execute any documents and to do everything necessary to effect such
      resignation or resignations on the Executive's behalf.

	 	
       
	
       
	
       

	22. 	
      DISCIPLINARY AND GRIEVANCE PROCEDURES

	 	
       
	
       
	
       

		
      22.1 
	
      There is no disciplinary procedure applicable to the
      Executive.

	 	
       
	
       
	
       

		
      22.2 
	
      The Executive is expected:

	 	
       
	
       
	
       

			
      22.2.1 
	
      to conduct herself in a suitable manner; and

	 	
       
	
       
	
       

			
      22.2.2 
	
      to exhibit the standard of behaviour commensurate with
      her position.

	 	
       
	
       
	
       

		
      22.3 
	
      If the Executive has any grievance relating to this
      Agreement, she should raise it with the Chairman and thereafter (if the
      matter is not resolved) with the Board.

	 	
       
	
       
	
       

	23. 	
      DATA PROTECTION

	 	
       
	
       
	
       

		
      23.1 
	
      The Company shall hold personal data in relation to the
      Executive in its manual and automated filing systems.

	 	
       
	
       
	
       

		
      23.2 
	
      The Executive consents to the processing and disclosure
      of such data both inside and, where necessary, outside the European
      Economic Area.

	 	
       
	
       
	
       

		
      23.3 
	
      The Executive agrees that personal information relating
      to the Executive may be disclosed for marketing and/or PR purposes and in
      connection with the performance of the services under this
    Agreement.

	 	
       
	
       
	
       

		
      23.4 
	
      The Executive agrees to use all reasonable endeavours to
      keep the Company informed of any changes to the Executive’s personal
      data.

	 	
       
	
       
	
       

		
      23.5 
	
      The Executive agrees to adhere to the Company's
      reasonable data protection rules and procedures insofar as he is informed
      of them.

	 	
       
	
       
	
       

	24. 	
      E-MAIL AND INTERNET POLICY

	 	
       
	
       
	
       

		
      The Executive agrees to adhere to the Company's e-mail
      and internet policy insofar as she is informed of
it.

13

	25. 	
      COLLECTIVE AGREEMENTS

	 	 	 	 
		
      There are no collective agreements with Trade Unions that
      directly affect the terms and conditions of this Agreement.

	 	 	 	 
	26. 	
      NOTICES

	 	 	 	 
		26.1 	
      Any notice to be given under this Agreement to the
      Executive may be

	 	 	 	 
			26.1.1 	
      given to the Executive personally or

	 	 	 	 
			26.1.2 	
      sent to her by pre-paid first class letter or

	 	 	 	 
			26.1.3 	
      sent by facsimile transmission addressed to her at her
      last known place of residence.

	 	 	 	 
		26.2 	
      Any notice to be given to the Company:

	 	 	 	 
			26.2.1 	
      should be addressed to the Chairman; and

	 	 	 	 
			26.2.2 	
      may be served by leaving it at or sending it by pre-paid
      first class letter to its UK representative office for the time
    being.

	 	 	 	 
		26.3 	
      Any notice served by post shall be deemed to have been
      served forty-eight hours after it was posted and proof that the notice was
      properly addressed, pre-paid and posted shall be sufficient evidence of
      service.

	 	 	 	 
	27. 	
      PRIOR AGREEMENTS

	 	 	 	 
		
      With the exception of the Consultancy Agreement and the
      Incentive Scheme entered or to be entered into between the Executive and a
      Group Company, this Agreement cancels and is in substitution for all
      previous letters of engagement, agreements and arrangements (whether oral
      or in writing) relating to the subject matter hereof between the Company
      or any Group Company and the Executive all of which shall be deemed to
      have been terminated by mutual consent.

	 	 	 	 
	28. 	
      RIGHTS OF THIRD PARTIES

	 	 	 	 
		
      This Agreement does not confer rights on the Executive's
      spouse or dependants or on any third party.

	 	 	 	 
	29. 	
      GOVERNING LAW AND JURISDICTION

	 	 	 	 
		29.1 	
      This Agreement shall be governed by and interpreted in
      accordance with the law of England.

	 	 	 	 
		29.2 	
      The parties to this Agreement submit to the exclusive
      jurisdiction of the English Courts in relation to any claim, dispute or
      matter arising out of or relating to this
Agreement.

14

	 	29.3 	
      Any delay by any party in exercising any of its or her
      rights under this Agreement will not constitute a waiver of such
      rights.

IN WITNESS of which the parties have executed this
Agreement on the date set out above.

EXECUTED by the Company which was delivered when dated,
acting by:

	Chief Operating Officer 	  
	Signature 	: /s/ Graham May 
	 	 
	Name 	: Graham May 

EXECUTED by the Executive which was delivered when
dated:

	Signature 	: /s/ Karen Elizabeth Jervis
  

15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]